These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 19608910)

  • 1. Demographic variability, vaccination, and the spatiotemporal dynamics of rotavirus epidemics.
    Pitzer VE; Viboud C; Simonsen L; Steiner C; Panozzo CA; Alonso WJ; Miller MA; Glass RI; Glasser JW; Parashar UD; Grenfell BT
    Science; 2009 Jul; 325(5938):290-4. PubMed ID: 19608910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rotavirus Infection: A Disease of the Past?
    Dennehy PH
    Infect Dis Clin North Am; 2015 Dec; 29(4):617-35. PubMed ID: 26337738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Temporal Association of Rotavirus Vaccine Introduction and Reduction in All-Cause Childhood Diarrheal Hospitalizations in South Africa.
    Groome MJ; Zell ER; Solomon F; Nzenze S; Parashar UD; Izu A; Madhi SA
    Clin Infect Dis; 2016 May; 62 Suppl 2():S188-95. PubMed ID: 27059355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamic model of rotavirus transmission and the impact of rotavirus vaccination in Kyrgyzstan.
    de Blasio BF; Kasymbekova K; Flem E
    Vaccine; 2010 Nov; 28(50):7923-32. PubMed ID: 20933563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness analysis of rotavirus vaccination in Argentina.
    Urueña A; Pippo T; Betelu MS; Virgilio F; Hernández L; Giglio N; Gentile Á; Diosque M; Vizzotti C
    Vaccine; 2015 May; 33 Suppl 1():A126-34. PubMed ID: 25919152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness analysis of the introduction of rotavirus vaccine in Iran.
    Javanbakht M; Moradi-Lakeh M; Yaghoubi M; Esteghamati A; Mansour Ghanaie R; Mahmoudi S; Shamshiri AR; Zahraei SM; Baxter L; Shakerian S; Chaudhri I; Fleming JA; Munier A; Baradaran HR
    Vaccine; 2015 May; 33 Suppl 1():A192-200. PubMed ID: 25919160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rotavirus infection: an update on management and prevention.
    Dennehy PH
    Adv Pediatr; 2012; 59(1):47-74. PubMed ID: 22789574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Timing of Birth as an Emergent Risk Factor for Rotavirus Hospitalization and Vaccine Performance in the Postvaccination Era in the United States.
    Lopman B; Dahl R; Shah M; Parashar UD
    Am J Epidemiol; 2018 Aug; 187(8):1745-1751. PubMed ID: 29546358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modelling the epidemiological impact of rotavirus vaccination in Germany--a Bayesian approach.
    Weidemann F; Dehnert M; Koch J; Wichmann O; Höhle M
    Vaccine; 2014 Sep; 32(40):5250-7. PubMed ID: 25045820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating the first introduction of rotavirus vaccine in Thailand: Moving from evidence to policy.
    Tharmaphornpilas P; Jiamsiri S; Boonchaiya S; Rochanathimoke O; Thinyounyong W; Tuntiwitayapun S; Guntapong R; Riewpaiboon A; Rasdjarmrearnsook AO; Glass RI
    Vaccine; 2017 Feb; 35(5):796-801. PubMed ID: 28057385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact and Effectiveness of Monovalent Rotavirus Vaccine Against Severe Rotavirus Diarrhea in Ghana.
    Armah G; Pringle K; Enweronu-Laryea CC; Ansong D; Mwenda JM; Diamenu SK; Narh C; Lartey B; Binka F; Grytdal S; Patel M; Parashar U; Lopman B
    Clin Infect Dis; 2016 May; 62 Suppl 2(Suppl 2):S200-7. PubMed ID: 27059357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cost-effectiveness of pentavalent rotavirus vaccination in England and Wales.
    Atkins KE; Shim E; Carroll S; Quilici S; Galvani AP
    Vaccine; 2012 Nov; 30(48):6766-76. PubMed ID: 23000223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of vaccine on rotavirus disease in the pediatric population.
    Dennehy PH
    Curr Opin Pediatr; 2012 Feb; 24(1):76-84. PubMed ID: 22189398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Public Health Impact of Complete and Incomplete Rotavirus Vaccination among Commercially and Medicaid Insured Children in the United States.
    Krishnarajah G; Duh MS; Korves C; Demissie K
    PLoS One; 2016; 11(1):e0145977. PubMed ID: 26751375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of transmission dynamics on the cost-effectiveness of rotavirus vaccination.
    Shim E; Galvani AP
    Vaccine; 2009 Jun; 27(30):4025-30. PubMed ID: 19389452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction in rotavirus after vaccine introduction--United States, 2000-2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Oct; 58(41):1146-9. PubMed ID: 19847149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rotarix®: vaccine performance 6 years postlicensure.
    O'Ryan M; Lucero Y; Linhares AC
    Expert Rev Vaccines; 2011 Dec; 10(12):1645-59. PubMed ID: 22085167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of rotavirus vaccination on hospitalizations for rotavirus diarrhea: the IVANHOE study.
    Gagneur A; Nowak E; Lemaitre T; Segura JF; Delaperrière N; Abalea L; Poulhazan E; Jossens A; Auzanneau L; Tran A; Payan C; Jay N; de Parscau L; Oger E;
    Vaccine; 2011 May; 29(21):3753-9. PubMed ID: 21443962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The rotavirus experience in Mexico: discovery to control.
    Patel MM; Parashar UD; Santosham M; Richardson V
    Clin Infect Dis; 2013 Feb; 56(4):548-51. PubMed ID: 23271788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing the Likely Impact of a Rotavirus Vaccination Program in England: The Contribution of Syndromic Surveillance.
    Bawa Z; Elliot AJ; Morbey RA; Ladhani S; Cunliffe NA; O'Brien SJ; Regan M; Smith GE
    Clin Infect Dis; 2015 Jul; 61(1):77-85. PubMed ID: 25828997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.